Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

GBD 2021 Pulmonary Arterial Hypertension Collaborators,Peter J Leary,Megan Lindstrom,Catherine O Johnson,Sophia Emmons-Bell,Stuart Rich,Paul A Corris,Hilary M DuBrock,Corey E Ventetuolo,Yohannes Habtegiorgis Abate,Michael Abdelmasseh,Richard Gyan Aboagye,Hasan Abualruz,Eman Abu-Gharbieh,Salahdein Aburuz,Lawan Hassan Adamu,Rui Adão,Isaac Yeboah Addo,Rufus Adesoji Adedoyin,Juliana Bunmi Adetunji,Leticia Akua Adzigbli,Bright Opoku Ahinkorah,Firdos Ahmad,Amir Mahmoud Ahmadzade,Ayman Ahmed,Haroon Ahmed,Syed Anees Ahmed,Shiva Akhlaghi,Mohammed Ahmed Akkaif,Salah Al Awaidy,Samer O Alalalmeh,Almaza Albakri,Khalifah A Aldawsari,Wael Almahmeed,Najim Z Alshahrani,Awais Altaf,Hany Aly,Karem H Alzoubi,Walid Adnan Al-Zyoud,Reza Amani,Ganiyu Adeniyi Amusa,Catalina Liliana Andrei,Saleha Anwar,Anayochukwu Edward Anyasodor,Aleksandr Y Aravkin,Demelash Areda,Haftu Asmerom Asmerom,Avinash Aujayeb,Ahmed Y Azzam,Abraham Samuel Babu,Sara Bagherieh,Ovidiu Constantin Baltatu,Hiba Jawdat Barqawi,Mohammad-Mahdi Bastan,Kavita Batra,Nebiyou Simegnew Bayleyegn,Amir Hossein Behnoush,Jaideep Singh Bhalla,Sonu Bhaskar,Vivek Bhat,Saeid Bitaraf,Veera R Bitra,Archith Boloor,Dejana Braithwaite,Michael Brauer,Lemma N Bulto,Yasser Bustanji,Vijay Kumar Chattu,Gerald Chi,Fatemeh Chichagi,Bryan Chong,Rajiv Chowdhury,Zinhle Cindi,Natalia Cruz-Martins,Sriharsha Dadana,Omid Dadras,Tukur Dahiru,Xiaochen Dai,Mohadese Dashtkoohi,Sean DeAngelo,Shayom Debopadhaya,Berecha Hundessa Demessa,Hardik Dineshbhai Desai,Vishal R Dhulipala,Michael J Diaz,Mengistie Diress,Thanh Chi Do,Thao Huynh Phuong Do,Khanh Duy Doan,Wendel Mombaque Dos Santos,Rajkumar Prakashbhai Doshi,Robert Kokou Dowou,Arkadiusz Marian Dziedzic,Muhammed Elhadi,Farshid Etaee,Natalia Fabin,Adeniyi Francis Fagbamigbe,Pawan Sirwan Faris,Bikila Regassa Feyisa,Celia Fortuna Rodrigues,Aravind P Gandhi,Mohammad Arfat Ganiyani,Yibeltal Yismaw Gela,Molla Getie,Amir Ghaffari Jolfayi,Afsaneh Ghasemzadeh,Mohamad Goldust,Mahaveer Golechha,Shi-Yang Guan,Mesay Dechasa Gudeta,Mohak Gupta,Rahul Gupta,Mostafa Hadei,Ahmad Hammoud,Md Saquib Hasnain,Mahgol Sadat Hassan Zadeh Tabatabaei,Simon I Hay,Omar E Hegazi,Mehdi Hemmati,Yuta Hiraike,Nguyen Quoc Hoan,Michael Hultström,Hong-Han Huynh,Segun Emmanuel Ibitoye,Olayinka Stephen Ilesanmi,Nahlah Elkudssiah Ismail,Chidozie Declan Iwu,Khushleen Jaggi,Akhil Jain,Mihajlo Jakovljevic,Sun Ha Jee,Bijay Mukesh Jeswani,Anil K Jha,Mohammad Jokar,Nitin Joseph,Jacek Jerzy Jozwiak,Hannaneh Kabir,Farima Kahe,Arun Kamireddy,Arun R Kanmanthareddy,Hanie Karimi,Arman Karimi Behnagh,Sina Kazemian,Pedram Keshavarz,Amirmohammad Khalaji,Mohammad Jobair Khan,Feriha Fatima Khidri,Min Seo Kim,Shivakumar Km Marulasiddaiah Kondlahalli,Nikhil Kothari,Kewal Krishan,Mukhtar Kulimbet,Ashish Kumar,Kaveh Latifinaibin,Thao Thi Thu Le,Caterina Ledda,Seung Won Lee,Ming-Chieh Li,Stephen S Lim,Shuke Liu,Elham Mahmoudi,Omar M Makram,Kashish Malhotra,Ahmad Azam Malik,Deborah Carvalho Malta,Yosef Manla,Miquel Martorell,Kamran Mehrabani-Zeinabad,Mohsen Merati,Tomislav Mestrovic,Niloofar Mirdamadi,Arup Kumar Misra,Ali H Mokdad,Mohammad Ali Moni,AmirAli Moodi Ghalibaf,Paula Moraga,Negar Morovatdar,Rohith Motappa,Seyed Ali Mousavi-Aghdas,Ahmad Mustafa,Ganesh R Naik,Mohammad Sadeq Najafi,Soroush Najdaghi,Dhairya P Nanavaty,Delaram Narimani Davani,Zuhair S Natto,Javaid Nauman,Dang H Nguyen,Phat Tuan Nguyen,Robina Khan Niazi,Bogdan Oancea,Titilope O Olanipekun,Gláucia Maria Moraes Oliveira,Hany A Omar,Mahesh Padukudru P A,Feng Pan,Seithikurippu R Pandi-Perumal,Ioannis Pantazopoulos,Romil R Parikh,Ionela-Roxana Petcu,Hoang Nhat Pham,Hoang Tran Pham,Anil K Philip,Elton Junio Sady Prates,Jagadeesh Puvvula,Gangzhen Qian,Quinn Rafferty,Fakher Rahim,Mehran Rahimi,Mosiur Rahman,Muhammad Aziz Rahman,Mohammad Rahmanian,Nazanin Rahmanian,Masoud Rahmati,Rahem Rahmati,Mahmoud Mohammed Ramadan,Kamleshun Ramphul,Juwel Rana,Indu Ramachandra Rao,Sina Rashedi,Nakul Ravikumar,Salman Rawaf,Ayita Ray,Murali Mohan Rama Krishna Reddy,Elrashdy Moustafa Mohamed Redwan,Negar Rezaei,Priyanka Roy,Aly M A Saad,Basema Ahmad Saddik,Masoumeh Sadeghi,Mohammad Reza Saeb,Fatemeh Saheb Sharif-Askari,Narjes Saheb Sharif-Askari,Mohamed A Saleh,Najib Yahaya Sani,Ushasi Saraswati,Aswini Saravanan,Jennifer Saulam,Art Schuermans,Austin E Schumacher,Birhan Ewunu Semagn,Yashendra Sethi,Allen Seylani,Melika Shafeghat,Moyad Jamal Shahwan,Muhammad Aaqib Shamim,Anas Shamsi,Sadaf Sharfaei,Kamal Sharma,Nitish Sharma,Akil Adrian Sherif,Ivy Shiue,Seyed Afshin Shorofi,Emmanuel Edwar Siddig,Harpreet Singh,Jasvinder A Singh,Paramdeep Singh,Surjit Singh,Farrukh Sobia,Ranjan Solanki,Shipra Solanki,Michael Spartalis,Chandan Kumar Swain,Lukasz Szarpak,Seyyed Mohammad Tabatabaei,Celine Tabche,Jacques Lukenze Tamuzi,Ker-Kan Tan,Masayuki Teramoto,Samar Tharwat,Friedrich Thienemann,Thien Tan Tri Tai Truyen,Guesh Mebrahtom Tsegay,Aniefiok John Udoakang,Jef Van den Eynde,Shoban Babu Varthya,Madhur Verma,Dominique Vervoort,Manish Vinayak,Maria Viskadourou,Fang Wang,Nuwan Darshana Wickramasinghe,Angga Wilandika,Suowen Xu,Chuanhua Yu,Iman Zare,Mohammad A Zeineddine,Zhi-Jiang Zhang,Lei Zhu,Abzal Zhumagaliuly,Magdalena Zielińska,Samer H Zyoud,Christopher J L Murray,Gregory A Roth

DOI: https://doi.org/10.1016/S2213-2600(24)00295-9

2024-10-18

Abstract:Background: Pulmonary arterial hypertension (PAH) is a vascular disease characterised by restricted flow and high pressure through the pulmonary arteries, leading to progressive right heart failure and death. This study reports the global burden of PAH, leveraging all available data and using methodology of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) to understand the epidemiology of this under-researched and morbid disease. Methods: Prior to the current effort, the burden of PAH was included in GBD as a non-specific contributor to "other cardiovascular and circulatory disease" burden. In this study, PAH was distinguished as its own cause of death and disability in GBD, producing comparable and consistent estimates of PAH burden. We used epidemiological and vital registry data to estimate the non-fatal and fatal burden of PAH in 204 countries and territories from 1990 to 2021 using standard GBD modelling approaches. We specifically focused on PAH (group 1 pulmonary hypertension), and did not include pulmonary hypertension groups 2-5. Findings: In 2021, there were an estimated 192 000 (95% uncertainty interval [UI] 155 000-236 000) prevalent cases of PAH globally. Of these, 119 000 (95 900-146 000) were in females (62%) and 73 100 (58 900-89 600) in males (38%). The age-standardised prevalence was 2·28 cases per 100 000 population (95% UI 1·85-2·80). Prevalence increased with age such that the highest prevalence was among individuals aged 75-79 years. In 2021, there were 22 000 deaths (18 200-25 400) attributed to PAH globally, with an age-standardised mortality rate of 0·27 deaths from PAH per 100 000 population (0·23-0·32). The burden of disease appears to be improving over time (38·2% improvement in age-standardised years of life lost [YLLs] in 2021 relative to 1990). YLLs attributed to PAH were similar to estimates for conditions such as chronic myeloid leukaemia, multiple sclerosis, and Crohn's disease. Interpretation: PAH is a rare but fatal disease that accounts for a considerable health-associated burden worldwide. PAH is disproportionally diagnosed among females and older adults. Funding: Cardiovascular Medical Research and Education Fund and the Bill & Melinda Gates Foundation.